Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Foeldvari

Showing results (111-120 of 174) with videos related to

Pageof 18
Sort By:
Arthritis and Rheumatism|March 3, 2007
The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosisFrancesco Zulian, Patricia Woo, Balu H Athreya, et al.
Arthritis Research & Therapy|June 25, 2024
S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritisHermine I Brunner, Grant S Schulert, Alyssa Sproles, et al.
Pediatric Rheumatology Online Journal|May 19, 2025
Bayesian trial of adalimumab versus secukinumab for children with juvenile idiopathic arthritis associated uveitis or chronic anterior uveitisAthimalaipet V Ramanan, Andrew D Dick, Thomas Jaki, et al.
Arthritis Care & Research|May 31, 2022
New and Updated Recommendations for the Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis and Idiopathic Chronic Anterior UveitisIvan Foeldvari, Ilaria Maccora, Harry Petrushkin, et al.
Arthritis Care & Research|October 11, 2016
International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D SyndromeSeza Ozen, Jasmin B Kuemmerle-Deschner, Rolando Cimaz, et al.
Arthritis Care & Research|April 3, 2025
Monitoring of Juvenile Idiopathic Arthritis-Associated Uveitis in Long-Term Disease Remission: Consensus-Based Recommendations From the Multinational Interdisciplinary Working Group for Uveitis in ChildhoodIvan Foeldvari, Ameenat Solebo, Harry Petrushkin, et al.
Arthritis Research & Therapy|May 27, 2026
Serological biomarkers of JIA-associated uveitis: ANA titers, ANA AC-30 staining pattern and prefoldin 5 antibodiesHeinrike Schmeling, Jens Klotsche, Babatope O Adebiyi, et al.
Pediatric Rheumatology Online Journal|December 29, 2017
Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter studyNicolino Ruperto, Hermine I Brunner, Zbigniew Zuber, et al.
Annals of the Rheumatic Diseases|March 4, 2019
Consensus-based recommendations for the management of juvenile localised sclerodermaFrancesco Zulian, Roberta Culpo, Francesca Sperotto, et al.
RMD Open|February 15, 2024
Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registryJasmin B Kuemmerle-Deschner, Tilmann Kallinich, Joerg Henes, et al.
Pageof 18

Showing results (111-120 of 174) with videos related to

Sort By:
Pageof 18
Arthritis and Rheumatism|March 3, 2007
The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosisFrancesco Zulian, Patricia Woo, Balu H Athreya, et al.
Arthritis Research & Therapy|June 25, 2024
S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritisHermine I Brunner, Grant S Schulert, Alyssa Sproles, et al.
Pediatric Rheumatology Online Journal|May 19, 2025
Bayesian trial of adalimumab versus secukinumab for children with juvenile idiopathic arthritis associated uveitis or chronic anterior uveitisAthimalaipet V Ramanan, Andrew D Dick, Thomas Jaki, et al.
Arthritis Care & Research|May 31, 2022
New and Updated Recommendations for the Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis and Idiopathic Chronic Anterior UveitisIvan Foeldvari, Ilaria Maccora, Harry Petrushkin, et al.
Arthritis Care & Research|October 11, 2016
International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D SyndromeSeza Ozen, Jasmin B Kuemmerle-Deschner, Rolando Cimaz, et al.
Arthritis Care & Research|April 3, 2025
Monitoring of Juvenile Idiopathic Arthritis-Associated Uveitis in Long-Term Disease Remission: Consensus-Based Recommendations From the Multinational Interdisciplinary Working Group for Uveitis in ChildhoodIvan Foeldvari, Ameenat Solebo, Harry Petrushkin, et al.
Arthritis Research & Therapy|May 27, 2026
Serological biomarkers of JIA-associated uveitis: ANA titers, ANA AC-30 staining pattern and prefoldin 5 antibodiesHeinrike Schmeling, Jens Klotsche, Babatope O Adebiyi, et al.
Pediatric Rheumatology Online Journal|December 29, 2017
Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter studyNicolino Ruperto, Hermine I Brunner, Zbigniew Zuber, et al.
Annals of the Rheumatic Diseases|March 4, 2019
Consensus-based recommendations for the management of juvenile localised sclerodermaFrancesco Zulian, Roberta Culpo, Francesca Sperotto, et al.
RMD Open|February 15, 2024
Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registryJasmin B Kuemmerle-Deschner, Tilmann Kallinich, Joerg Henes, et al.
Pageof 18